O'Kane Kieran sold BDSX

February 9, 2026 · Form 4 insider transaction

O'Kane Kieran sold 73 shares of Biodesix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
73
Price
$0.00
Total value
N/A
RoleOfficer
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date.

View the original Form 4 on SEC EDGAR